These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 34938730)
1. Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment. Jiang Z; Xing C; Wang P; Liu X; Zhong L Front Cell Dev Biol; 2021; 9():748269. PubMed ID: 34938730 [No Abstract] [Full Text] [Related]
2. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment. Zeng Q; Sun S; Li Y; Li X; Li Z; Liang H Front Oncol; 2019; 9():1555. PubMed ID: 32117786 [No Abstract] [Full Text] [Related]
3. Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer. Tian Y; Xie Y; Yi G; Wu F; Dang X; Bai F; Wang J; Zhang D Curr Med Chem; 2024; 31(42):7043-7058. PubMed ID: 39129286 [TBL] [Abstract][Full Text] [Related]
4. The Prognostic Significance of Li Z; Cui Y; Duan Q; Zhang J; Shao D; Cao X; Gao Y; Wang S; Li J; Jones OD; Lei X; Wang L; Zhou X; Xu M; Ma J; Liu Y; Xu X Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361587 [TBL] [Abstract][Full Text] [Related]
5. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment. Yin Z; Ma T; Chen S; Yu M Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723 [TBL] [Abstract][Full Text] [Related]
6. CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target. Jiang Q; Kuai J; Jiang Z; Que W; Wang P; Huang W; Ding W; Zhong L Front Immunol; 2023; 14():1158360. PubMed ID: 37483608 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis. Han X; Long W; Liu Y; Xu J Front Surg; 2022; 9():985034. PubMed ID: 36338652 [TBL] [Abstract][Full Text] [Related]
8. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients. Huang B; Han W; Sheng ZF; Shen GL Cancer Cell Int; 2020; 20():195. PubMed ID: 32508531 [TBL] [Abstract][Full Text] [Related]
9. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma. Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532 [TBL] [Abstract][Full Text] [Related]
10. Tan Z; Chen M; Peng F; Yang P; Peng Z; Zhang Z; Li X; Zhu X; Zhang L; Zhao Y; Liu Y Transl Cancer Res; 2022 Aug; 11(8):2713-2732. PubMed ID: 36093522 [TBL] [Abstract][Full Text] [Related]
11. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma. Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863 [TBL] [Abstract][Full Text] [Related]
12. Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment. Wang J; Zhang C; Chen X; Li Y; Li A; Liu D; Li F; Luo T Transl Cancer Res; 2021 May; 10(5):2169-2187. PubMed ID: 35116536 [TBL] [Abstract][Full Text] [Related]
13. PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma. Jin W; Wang G; Dong M; Wang X Eur J Med Res; 2024 Mar; 29(1):177. PubMed ID: 38494503 [TBL] [Abstract][Full Text] [Related]
14. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines. Sun X; Chen Q; Zhang L; Chen J; Zhang X Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533 [TBL] [Abstract][Full Text] [Related]
15. Regulator of nonsense transcripts 3B is a prognostic biomarker and associated with immune cell infiltration in lung squamous cell and hepatocellular carcinoma. Li P; Zhou M; Gan X; Yuan C; Li G; Jin GN; Ding ZY Discov Oncol; 2024 Sep; 15(1):479. PubMed ID: 39331207 [TBL] [Abstract][Full Text] [Related]
16. ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC. Zhou L; Fu Z; Wang S; Jia J; Cheng Y; Zheng Y; Zhang N; Lu W; Yao Z Front Oncol; 2022; 12():875097. PubMed ID: 35586489 [TBL] [Abstract][Full Text] [Related]
17. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma. Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158 [No Abstract] [Full Text] [Related]
18. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis. Wu C; Ma C; Yuan J; Zhou P Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296 [TBL] [Abstract][Full Text] [Related]
19. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma. Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618 [TBL] [Abstract][Full Text] [Related]
20. Identification of ABCC5 Among ATP-Binding Cassette Transporter Family as a New Biomarker for Hepatocellular Carcinoma Based on Bioinformatics Analysis. Qiu Y; Li H; Xie J; Qiao X; Wu J Int J Gen Med; 2021; 14():7235-7246. PubMed ID: 34737618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]